Neurocrine Biosciences Inc Sustainability Reports
Neurocrine Biosciences, Inc. is a biopharmaceutical company discovering, developing, and commercializing treatments for neurological, neuroendocrine, and neuropsychiatric disorders. The company's diverse product portfolio features treatments for tardive dyskinesia, Huntington's disease chorea, and classic congenital adrenal hyperplasia.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300FECER0XBN49756
FIGI: BBG001S8W4X9
17 reports from 2008 to 2026
